| Open Document File Size: 447,65 KBShare Result on Facebook
City Maestri / Chicago / / Company ABBOTT Pharmaceutical Products Division Abbott Laboratories / Abbott Laboratories / MD Divisional / / Event Product Issues / / IndustryTerm gas chromatography / valproate products / nontoxic elimination end-product / / MedicalCondition suspected urea cycle disorders / hyperammonemic encephalopathy / unexplained mental retardation / unexplained lethargy / urea cycle disorders / unexplained encephalopathy / coma / WARNINGS Urea Cycle Disorders / respiratory alkalosis / lethargy / unexplained hyperammonemic encephalopathy / vomiting / encephalopathy / cyclical vomiting / deficiency / particularly ornithine transcarbamylase deficiency / ataxia / low BUN / postpartum encephalopathy / / Organization FDA / / Person Tracey Heimberger / / / Position Vice President / Global Medical Services References / / Product ER Tablets / Depakene / Depacon / divalproex sodium / valproic acid / valproate sodium / Depakote / ability / / ProvinceOrState Nebraska / Illinois / / RadioStation Rudolph AM / / Technology spectroscopy / gas chromatography / / URL www.fda.gov/medwatch / /
SocialTag |